Selection of an antiarrhythmic drug for a sudden-death-prevention trial.
Woosley, R L
Selection of an antiarrhythmic drug for a sudden-death-prevention trial. [electronic resource] - American heart journal Apr 1982 - 737-45 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S.
0002-8703
10.1016/0002-8703(82)90481-1 doi
Acecainide--therapeutic use
Amiodarone--therapeutic use
Anilides--therapeutic use
Anti-Arrhythmia Agents--therapeutic use
Aprindine--therapeutic use
Arrhythmias, Cardiac--mortality
Benzeneacetamides
Bretylium Compounds--therapeutic use
Clinical Trials as Topic
Death, Sudden
Encainide
Flecainide
Humans
Kinetics
Lidocaine--analogs & derivatives
Mexiletine--therapeutic use
Moricizine
Morpholines--therapeutic use
Phenothiazines--therapeutic use
Piperidines--therapeutic use
Tocainide
Verapamil--therapeutic use
Selection of an antiarrhythmic drug for a sudden-death-prevention trial. [electronic resource] - American heart journal Apr 1982 - 737-45 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S.
0002-8703
10.1016/0002-8703(82)90481-1 doi
Acecainide--therapeutic use
Amiodarone--therapeutic use
Anilides--therapeutic use
Anti-Arrhythmia Agents--therapeutic use
Aprindine--therapeutic use
Arrhythmias, Cardiac--mortality
Benzeneacetamides
Bretylium Compounds--therapeutic use
Clinical Trials as Topic
Death, Sudden
Encainide
Flecainide
Humans
Kinetics
Lidocaine--analogs & derivatives
Mexiletine--therapeutic use
Moricizine
Morpholines--therapeutic use
Phenothiazines--therapeutic use
Piperidines--therapeutic use
Tocainide
Verapamil--therapeutic use